These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 30935089)
1. Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol. Sorber L; Zwaenepoel K; Jacobs J; De Winne K; Goethals S; Reclusa P; Van Casteren K; Augustus E; Lardon F; Roeyen G; Peeters M; Van Meerbeeck J; Rolfo C; Pauwels P Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30935089 [TBL] [Abstract][Full Text] [Related]
2. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814 [TBL] [Abstract][Full Text] [Related]
3. Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology. Diaz IM; Nocon A; Held SAE; Kobilay M; Skowasch D; Bronkhorst AJ; Ungerer V; Fredebohm J; Diehl F; Holdenrieder S; Holtrup F Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046506 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of circulating tumor DNA stability In K Kang Q; Henry NL; Paoletti C; Jiang H; Vats P; Chinnaiyan AM; Hayes DF; Merajver SD; Rae JM; Tewari M Clin Biochem; 2016 Dec; 49(18):1354-1360. PubMed ID: 27129799 [TBL] [Abstract][Full Text] [Related]
5. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA. Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211 [TBL] [Abstract][Full Text] [Related]
6. A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. Norton SE; Lechner JM; Williams T; Fernando MR Clin Biochem; 2013 Oct; 46(15):1561-5. PubMed ID: 23769817 [TBL] [Abstract][Full Text] [Related]
7. Performance of ImproGene cfDNA blood collection tubes for mutation analysis in cancer patients. Zhang S; Zhou D; Li S; Bai Y; Huang B; Han J; Xu M; Wang S; Deng G Scand J Clin Lab Invest; 2022 Sep; 82(5):378-384. PubMed ID: 35861435 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma. Warton K; Yuwono NL; Cowley MJ; McCabe MJ; So A; Ford CE Mol Diagn Ther; 2017 Oct; 21(5):563-570. PubMed ID: 28631163 [TBL] [Abstract][Full Text] [Related]
10. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA. Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317 [No Abstract] [Full Text] [Related]
11. Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC). Sherwood JL; Corcoran C; Brown H; Sharpe AD; Musilova M; Kohlmann A PLoS One; 2016; 11(2):e0150197. PubMed ID: 26918901 [TBL] [Abstract][Full Text] [Related]
12. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR. Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523 [TBL] [Abstract][Full Text] [Related]
13. Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples. Wagner JT; Kim HJ; Johnson-Camacho KC; Kelley T; Newell LF; Spellman PT; Ngo TTM Sci Rep; 2020 Oct; 10(1):16456. PubMed ID: 33020547 [TBL] [Abstract][Full Text] [Related]
14. Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients. Risberg B; Tsui DWY; Biggs H; Ruiz-Valdepenas Martin de Almagro A; Dawson SJ; Hodgkin C; Jones L; Parkinson C; Piskorz A; Marass F; Chandrananda D; Moore E; Morris J; Plagnol V; Rosenfeld N; Caldas C; Brenton JD; Gale D J Mol Diagn; 2018 Nov; 20(6):883-892. PubMed ID: 30165204 [TBL] [Abstract][Full Text] [Related]
15. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors. Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903 [TBL] [Abstract][Full Text] [Related]
16. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection. Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860 [TBL] [Abstract][Full Text] [Related]
17. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples. Nesic M; Bødker JS; Terp SK; Dybkær K Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658 [TBL] [Abstract][Full Text] [Related]
18. Performance comparison of blood collection tubes as liquid biopsy storage system for minimizing cfDNA contamination from genomic DNA. Zhao Y; Li Y; Chen P; Li S; Luo J; Xia H J Clin Lab Anal; 2019 Feb; 33(2):e22670. PubMed ID: 30191594 [TBL] [Abstract][Full Text] [Related]